Keskikuru Riitta, Jukkola Arja, Nuutinen Jouni, Kataja Vesa, Risteli Juha, Autio Pekka, Lahtinen Tapani
Department of Oncology, Kuopio University Hospital, FIN-70210 Kuopio, Finland.
Radiother Oncol. 2004 Mar;70(3):243-8. doi: 10.1016/j.radonc.2003.11.014.
To measure local changes of collagen metabolism in irradiated breast skin and systemic changes in serum during and after radiotherapy and correlate these changes with skin thickness, erythema and palpable subcutaneous induration.
Aminoterminal propeptides of type I and type III procollagens (PINP and PIIINP, respectively) were measured from skin suction blister fluid (SBF) in 21 breast cancer patients with breast conserving surgery and conventionally fractionated radiotherapy (RT) to a total dose of 50Gy. Suction blisters were induced in the operated and contralateral breast skin before RT, at 2.5 weeks, at the end of RT, and at 1, 4, 7, 12 and 24 months post-treatment. Blood samples for serum were taken simultaneously with SBF induction. Skin thickness of the suction blister sites was measured with a high-frequency ultrasound device. The investigated sites were scored for erythema at the end of RT and palpable subcutaneous induration at 1 and 2 years post-treatment.
In SBF the mean levels of PINP and PIIINP of the operated breast before RT were about 3-4 times higher than those in the contralateral breast due to the operation-related wound healing. The synthesis of PINP in irradiated breast after RT increased 7.7-fold (P < 0.001) 4 months post-irradiation. The PIIINP synthesis was at maximum at 1 month post-irradiation (P < 0.001). Both synthesis stayed elevated until 2 years. The level of PINP correlated significantly with the palpable skin induration at 1 and 2 years (P = 0.038 and P = 0.003, respectively). The skin thickness of the irradiated breast was highest at 4 months post-treatment and significantly elevated until 1 year. The skin thickness correlated with the PINP level until 7 months and with PIIINP between 4 and 18 months. The PINP/PIIINP ratio reached the maximum at 4 months and stayed elevated until 2 years. No change in mean serum level of PINP was found during or after RT.
We demonstrated a maximum and elevated levels for PINP and PIIINP skin collagen metabolism determined from SBF during the 2 years' follow-up. Elevated levels of PINP and PIIINP correlated with the thickening of the skin and subcutaneous induration but not with erythema.
测量放疗期间及放疗后照射乳腺皮肤中胶原蛋白代谢的局部变化以及血清中的全身变化,并将这些变化与皮肤厚度、红斑和可触及的皮下硬结相关联。
对21例行保乳手术并接受常规分割放疗、总剂量达50Gy的乳腺癌患者,从皮肤吸引水疱液(SBF)中测量I型和III型前胶原的氨基末端前肽(分别为PINP和PIIINP)。在放疗前、放疗2.5周时、放疗结束时以及治疗后1、4、7、12和24个月,在手术侧和对侧乳腺皮肤诱导产生吸引水疱。与诱导产生SBF同时采集血样用于检测血清。用高频超声设备测量吸引水疱部位的皮肤厚度。在放疗结束时对研究部位的红斑进行评分,并在治疗后1年和2年对可触及的皮下硬结进行评分。
由于手术相关的伤口愈合,放疗前手术侧乳腺SBF中PINP和PIIINP的平均水平比对照侧乳腺高约3 - 4倍。放疗后照射乳腺中PINP的合成在照射后4个月增加了7.7倍(P < 0.001)。PIIINP合成在照射后1个月达到最大值(P < 0.001)。两种合成在2年内均持续升高。PINP水平与1年和2年时可触及的皮肤硬结显著相关(分别为P = 0.038和P = 0.003)。照射乳腺的皮肤厚度在治疗后4个月最高,并显著升高至1年。皮肤厚度在7个月前与PINP水平相关,在4至18个月与PIIINP相关。PINP/PIIINP比值在4个月时达到最大值,并持续升高至2年。放疗期间及放疗后未发现PINP血清平均水平有变化。
我们证实在2年的随访期间,从SBF中测定的照射乳腺皮肤中PINP和PIIINP的胶原蛋白代谢达到最大值且持续升高。PINP和PIIINP水平升高与皮肤增厚和皮下硬结相关,但与红斑无关。